Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2026-01-01 @ 5:00 PM
Study NCT ID:
NCT02794792
Status:
COMPLETED
Last Update Posted:
2024-11-12
First Post:
2016-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin
Sponsor:
Astellas Pharma Europe B.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-11
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-20
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-14
First Submit QC Date:
None
Study First Post Date:
2016-06-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-08
Last Update Post Date:
2024-11-12
Last Update Post Date Type:
ACTUAL